Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study

Autor: Rugo, H.S., O’Shaughnessy, J., Boyle, F., Toi, M., Broom, R., Blancas, I., Gumus, M., Yamashita, T., Im, Y.-H., Rastogi, P., Zagouri, F., Song, C., Campone, M., San Antonio, B., Shahir, A., Hulstijn, M., Brown, J., Zimmermann, A., Wei, R., Johnston, S.R.D., Reinisch, M., Tolaney, S.M.
Zdroj: In Annals of Oncology June 2022 33(6):616-627
Databáze: ScienceDirect